-+ 0.00%
-+ 0.00%
-+ 0.00%

Commit Biologics raises $60 million in seed financing with M Ventures participation

PUBT·11/17/2026 08:48:44
Listen to the news
Commit Biologics raises $60 million in seed financing with M Ventures participation
  • Commit Biologics completed a $60 million (€54 million) seed financing round on November 17, 2026, with participation from M Ventures.
  • Ackermans & van Haaren led the final close, with AbbVie Ventures also joining as a new investor.
  • The biotechnology company develops complement-powered immune engagers for cancer and autoimmune diseases.
  • Proceeds will take lead candidate COM002 toward clinical development, advance a second program into IND-enabling development and expand the pipeline.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck Ventures BV published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.